These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8462176)

  • 1. Genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of high density lipoprotein particles.
    Fruchart JC; Ailhaud G; Bard JM
    Circulation; 1993 Apr; 87(4 Suppl):III22-7. PubMed ID: 8462177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
    Dallinga-Thie GM; Dullaart RP; van Tol A
    Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids as a coronary risk factor: analysis of hyperlipidaemias.
    Hamsten A
    Postgrad Med J; 1993; 69 Suppl 1():S8-11. PubMed ID: 8497457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins.
    Cohn JS
    Can J Cardiol; 1998 May; 14 Suppl B():18B-27B. PubMed ID: 9627538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic dyslipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
    Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
    Masana L; Febrer G; Cavanna J; Baroni MG; Marz W; Hoffmann MM; Shine B; Galton DJ
    Clin Sci (Lond); 2001 Feb; 100(2):183-90. PubMed ID: 11171287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic basis of lipoprotein disorders. Introduction and overview.
    Breslow JL
    J Intern Med; 1992 Jun; 231(6):627-31. PubMed ID: 1535651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remnant hyperlipidemia and gene polymorphism].
    Tada N
    Nihon Rinsho; 1999 Dec; 57(12):2789-94. PubMed ID: 10638214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility.
    Breslow JL
    Annu Rev Genet; 2000; 34():233-254. PubMed ID: 11092828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease.
    Rifai N
    Arch Pathol Lab Med; 1986 Aug; 110(8):694-701. PubMed ID: 3524505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.